Study your flashcards anywhere!

Download the official Cram app for free >

  • Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

A key: Read text to speech.a key

image

Play button

image

Play button

image

Progress

1/106

Click to flip

106 Cards in this Set

  • Front
  • Back
epinephrine
nonselective AR agonist,
positive inotropic agent-primary, for CHF
norepinephrine
nonselective AR agonist
dopamine
nonselective AR agonist,
positive inotropic agent-primary drug, for CHF
isoproterenol
nonselective beta agonist,
positive chronotropic/dromotropic agent-secondary drug, for CHF
phenylephrine
selective alpha 1 agonist
clonidine
selective alpha 2 agonist,
sympatholytic agent acts on autonomic ganglion
dobutamine
selective beta 1 agonist,
positive inotropic agent-secondary drug
albuterol
selective beta 2 agonist
ephedrine
indirect AR agonist
amphetamine
indirect AR agonist
tyramine
indirect AR agonist
cocaine
indirect AR agonist
phentolamine
nonselective alpha antagonist, reversible
phenoxybenzamine
nonselective alpha antagonist, irreversible
prazosin
selective alpha 1 antagonist

afterload reducing agent (vasodilator) in CHF, primary drug
propranolol
nonselective beta antagonist

positive inotropic agent-secondary drug(for ASH, IHSS), for CHF

blocks peripheral adrenergic receptors

inhibits inappropriate proliferation/remodeling, for CHF
timolol
nonselective beta antagonist
pindolol
nonselective beta antagonist
sotalol
nonselective beta antagonist
metoprolol
selective beta 1 antagonist with some beta 2 antagonism
atenolol
selective beta 1 antagonist
labetolol
nonselective beta and alpha 1 antagonist
carvedilol
nonselective beta and alpha 1 antagonist
methacholine
cholinergic muscarinic agonist
bethanecol
cholinergic muscarinic agonist
pilocarpine
cholinergic muscarinic agonist
nicotine
direct, non-reversible nicotinic agonist
edrophonium
indirect cholinesterase agonist, cholinesterase inhibitor
physostigmine
carbamate cholinesterase inhibitor
neostigmine
carbamate cholinesterase inhibitor
pralidoxime
organophosphate cholinesterase inhibitor
echothiophate
organophosphate cholinesterase inhibitor
atropine
cholinergic muscarinic receptor blocker/antagonist

primary drug in CHF, positive chronotropic/dromotropic agents
scopolamine
cholinergic muscarinic receptor blocker/antagonist
benztropine
cholinergic muscarinic receptor blocker/antagonist
succinylcholine
cholinergic nicotinic receptor blocker/antagonist
blocker of NMJ, non-competitive
d-tubocurarine
cholinergic nicotinic receptor blocker/antagonist
blocker of NMJ, competitive
pancuronium
cholinergic nicotinic receptor blocker/antagonist
blocker of NMJ, competitive
vecuronium
cholinergic nicotinic receptor blocker/antagonist
blocker of NMJ, competitive
rocuronium
cholinergic nicotinic receptor blocker/antagonist
blocker of NMJ, competitive
cisatracurium
cholinergic nicotinic receptor blocker/antagonist
blocker of NMJ, competitive
trimethophan
cholinergic nicotinic receptor blocker/antagonist, blocker of ganglion, competitive,
sympatholytic agent acts on autonomic ganglion
botulinum toxin
acetylcholine release blocker
nitroprusside
direct vasodilator

afterload reducing agent (vasodilator) in CHF, primary drug
hydralazine
direct vasodilator, afterload reducing agent in CHF, primary drug
verapamil, nifedipine
indirect vasodilator, Ca channel blocker
reserpine
sympatholytic, acts on post-ganglionic neurons
atenolol
blocks peripheral adrenergic receptors
beta 1 blocker
prazosin
blocks peripheral adrenergic receptors
alpha 1 blocker
afterload reducing agent (vasodilator) for CHF, primary drug
labetolol
blocks peripheral adrenergic receptors
beta and alpha 1 blocker
albuterol
short acting beta 2 agonist
salmeterol and formoterol
long acting beta 2 agonist
atropine
anticholinergic bronchodilator
ipratropium
anticholinergic bronchodilator
salbuterol
anticholinergic bronchodilator
aminophylline
methyl xanthine
theophylline
methyl xanthine
adenosine receptor antagonist
sodium cromoglycate
anti-inflammatory
corticosteroids
anti-inflammatory
inhaled glucocorticoids
beclomethosone, triamcinolone, flunisolide, fluticasone, budesonide
anti-inflammatory
nitroglycerine
treatment of angina
beta blockers atenolol, metoprolol, propranolol
treatment of angina
Ca channel blockers verapamil, diltiazem, nifedipine
treatment of angina
for vasospastic angina (beta blockers contraindicated)
aspirin
treatment of angina
clopidogrel (Plavix)
treatment of angina
abciximab, tirofiban, eptifibitide
treatment of angina
hydrocortisone, prednisone, prednisolone, methylprednisolone
systemic glucocorticoids, anti-flammatory
zileuton
5' Liboxygenase inhibitor, leukotriene modulator, anti-inflammatory
montelukast
leukotriene receptor antagonist, anti-inflammatory, leukotriene modulators
omalizumab
anti-IgE Mab
phenylephrine
nasal decongestant
pseudoephedrine
nasal decongestant
dextromethorphan
anti-tussive (anti-cough) agent
Robitussin DM
codeine
anti-tussive (anti-cough) agent
histamine
trigger of asthma like methacholine
calcium chloride
positive chronotropic/dromotropic agent, secondary drug, for CHF
glucagon
positive chronotropic dromotropic agent, secondary drug, for CHF
amrinone
positive inotropic agent, primary drug, for CHF
digoxin
positive inotropic agent, primary drug, for CHF
milrinone
positive inotropic agent, secondary drug, for CHF
furosemide
preload reducing agent for CHF
lisinopril
afterload reducing agent (vasodilator) for CHF, primary drug

ACE inhibitor

inhibits inappropriate proliferation/remodeling, primary drug, for CHF
nitrates
afterload reducing agent (vasodilator) for CHF, primary drug
enalapril
ACE inhibitor
afterload reducing agent (vasodilator) for CHF, secondary drug

inhibits inappropriate proliferation/remodeling, secondary drug, for CHF
spironolactone
inhibits inappropriate proliferation/remodeling, primary drug, for CHF
losartan
ARB

inhibits inappropriate proliferation/remodeling, secondary drug, for CHF
quinidine
Na Channel Blockers Class 1A, supraventricular dysrhythmias
procainamide
Na Channel Blockers Class 1A, supraventricular dysrhythmias
disopyramide
Na Channel Blockers Class 1A, supraventricular dysrhythmias
lidocaine
Na Channel Blockers Class 1B, supraventricular dysrhythmias
mexilitene
Na Channel Blockers Class 1B, supraventricular dysrhythmias
tocainide
Na Channel Blockers Class 1B, supraventricular dysrhythmias
flecainide
Na Channel Blockers Class 1C, supraventricular dysrhythmias
propafenone
Na Channel Blockers Class 1C, supraventricular dysrhythmias
propranolol
class 2 supraventricular dysrhythmias, beta blocker
esmolol
class 2 supraventricular dysrhythmias, beta blocker
amiodarone
K+ channel blocker, class 3, supraventricular dysrhythmias
sotolol
K+ channel blocker, class 3, supraventricular dysrhythmias
ibutilide
K+ channel blocker, class 3, supraventricular dysrhythmias
diltiazem, verapamil
Ca++ channel blockers, Class 4, supraventricular dysrhythmias
digoxin, adenosine, isoproterenol, atropine
for supraventricular dysrhythmias
cholestyramine
lipid lowering drug
niacin
lipid lowering drug
gemfibrozil
lipid lowering drug
lovastatin
lipid lowering drug
ezetimibe
lipid lowering drug